CLINICAL PHARMACOKINETIC CONSIDERATIONS IN THE CONTROL OF ORAL ANTICOAGULANT-THERAPY

被引:40
作者
SHETTY, HGM [1 ]
FENNERTY, AG [1 ]
ROUTLEDGE, PA [1 ]
机构
[1] UNIV WALES COLL MED, DEPT PHARMACOL & THERAPEUT, HLTH PK, CARDIFF CF4 4XN, S GLAM, WALES
关键词
D O I
10.2165/00003088-198916040-00003
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:238 / 253
页数:16
相关论文
共 89 条
[1]  
AGGELER PM, 1966, THROMB DIATH HAEMOST, VS, P227
[2]   BLOOD COAGULATION IN PREGNANCY - PROCONVERTIN AND PROTHROMBIN, AND THE HYPERCOAGULABLE STATE [J].
ALEXANDER, B ;
MEYERS, L ;
KENNY, J ;
GOLDSTEIN, R ;
GUREWICH, V ;
GRINSPOON, L .
NEW ENGLAND JOURNAL OF MEDICINE, 1956, 254 (08) :358-363
[3]  
ANDERSEN P, 1975, ACTA MED SCAND, V198, P269
[4]  
ANDREASEN PB, 1974, CLIN PHARMACOL THER, V16, P1059
[5]   PROTEIN-BINDING OF COUMARIN ANTICOAGULANTS IN DISEASE STATES [J].
BACHMANN, K ;
SHAPIRO, R .
CLINICAL PHARMACOKINETICS, 1977, 2 (02) :110-126
[6]   PHENYLBUTAZONE-WARFARIN INTERACTION IN MAN - FURTHER STEREOCHEMICAL AND METABOLIC CONSIDERATIONS [J].
BANFIELD, C ;
OREILLY, R ;
CHAN, E ;
ROWLAND, M .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 16 (06) :669-675
[7]   INVESTIGATION OF PATIENTS WITH ABNORMAL RESPONSE TO WARFARIN [J].
BENTLEY, DP ;
BACKHOUSE, G ;
HUTCHINGS, A ;
HADDON, RL ;
SPRAGG, B ;
ROUTLEDGE, PA .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 22 (01) :37-41
[8]  
BRECKENRIDGE A, 1974, CLIN PHARMACOL THER, V15, P424
[9]  
BRODIE B B, 1959, Med Exp Int J Exp Med, V1, P290
[10]  
BRODIE BB, 1964, PHARMACOLOGIST, V6, P12